4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0001209191-23-045263
EVP, COO acquired 13,812 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lamothe Jeffrey G. EVP, COO | 2023-08-08 | Option exercise | +11,979 | 24,671 | D | ||
| Lamothe Jeffrey G. EVP, COO | 2023-08-08 | Option exercise | +1,833 | 26,504 | D | ||
| Derivatives | |||||||
| Lamothe Jeffrey G. EVP, COO | 2023-08-08 | Option exercise · Restricted Stock Unit | −11,979 | 11,979 | D | ||
| Lamothe Jeffrey G. EVP, COO | 2023-08-08 | Option exercise · Restricted Stock Unit | −1,833 | 3,667 | D | ||
Loading xslF345X05/doc4.xml…